• Sat. Mar 11th, 2023

Iris Lab new drugs, bio R&D companies

Bywiret

Aug 26, 2022

Iris Lab announced on the 26th that it has opened a shared laboratory at the Seoul Forest A1 Knowledge Industry Center in Seongsu-dong and is recruiting companies to move in.

The scope of the participating companies this time is prospective startups such as scientists and faculty with ideas and promising technologies, new drugs, bio R&D companies, and promising technology companies with new drug candidates. Applications for preliminary start-ups and early start-ups will be made online at all times.

Iris Lab has strong efficiency and flexibility as it focuses on creating an investment environment for startups and co-growth, an Iris Lab official said. “We will conduct business consulting that presents a customized roadmap based on experience and know-how for early startups’ growth.”

Meanwhile, Iris Lab plans to strengthen its platform through discovery of partner startup companies through technology evaluation and MOUs with government organizations, educational institutions, and venture investment companies. In addition, it plans to diversify its business structure by providing customized analysis and evaluation services.

Leave a Reply